Tandem Diabetes Care Income Statement
TNDM / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
Tandem Diabetes Care reported $1.0B in revenue and $205M in net loss for FY2025. Revenue has grown at a 58.8% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $940.2M | $747.7M | $498.8M | $362.3M | $183.9M | $107.6M | $84.2M | $72.8M | $84.2M | $72.8M | $2.5M | $29.0M | $2.5M |
| Cost of Revenue | $468.7M | $450.6M | $380.0M | $238.3M | $168.1M | $94.0M | $63.5M | $60.7M | $46.3M | $60.7M | $46.3M | $3.8M | $22.8M | $3.8M |
| Gross Profit | $546.0M | $489.6M | $367.7M | $260.5M | $194.2M | $89.8M | $44.1M | $23.6M | $26.6M | $23.6M | $26.6M | -$1.3M | $6.2M | -$1.3M |
| SG&A Expense | $445.0M | $389.8M | $352.5M | $204.9M | $165.7M | $105.2M | $86.4M | $82.8M | $78.6M | $82.8M | $78.6M | $22.7M | $44.5M | $22.7M |
| R&D Expense | $193.1M | $198.9M | $169.7M | $63.6M | $45.2M | $29.2M | $20.7M | $18.8M | $17.0M | $18.8M | $17.0M | $9.0M | $11.1M | $9.0M |
| Operating Income | -$187.3M | -$99.1M | -$233.2M | -$8.0M | -$16.7M | -$44.6M | -$62.9M | -$78.1M | -$69.0M | -$78.1M | -$69.0M | -$33.0M | -$49.4M | -$33.0M |
| Income Tax | $4.4M | $4.2M | $2.4M | -$1.9M | $149.0K | $51.0K | $8.0K | -$15.0K | $10.0K | -$15.0K | $10.0K | $71.0K | - | - |
| Net Income | -$204.7M | -$96.0M | -$222.6M | -$34.4M | -$24.8M | -$122.6M | -$73.0M | -$83.4M | -$72.4M | -$83.4M | -$72.4M | -$33.0M | -$63.1M | -$33.0M |
| EPS (Basic) | -$3.43 | -$1.47 | $0.25 | -$0.56 | -$0.42 | -$0.45 | -$0.40 | -$1.82 | - | - | - | - | - | - |
| EPS (Diluted) | -$3.43 | -$1.47 | $0.24 | -$0.56 | -$0.42 | -$0.45 | -$0.40 | -$1.82 | -$25.04 | -$3.42 | -$21.46 | -$175.88 | - | - |
| Shares Outstanding | 66.3M | 65.6M | 64.5M | 63.8M | 62.3M | 59.4M | 57.6M | 10.1M | 3.1M | 30.3M | 23.7M | 22.9M | 2.9M | 188.0K |
| Gross Margin | 53.8% | 52.1% | 49.2% | 52.2% | 53.6% | 48.9% | 41.0% | 28.0% | 36.5% | 28.0% | 36.5% | -54.5% | 21.3% | -54.5% |
| Operating Margin | -18.4% | -10.5% | -31.2% | -1.6% | -4.6% | -24.3% | -58.5% | -92.6% | -94.7% | -92.6% | -94.7% | -1335.3% | - | - |
| Profit Margin | -20.2% | -10.2% | -29.8% | -6.9% | -6.8% | -66.7% | -67.9% | -99.1% | -99.4% | -99.1% | -99.4% | -1333.9% | - | - |